Myriamed GmbH, KIST-Europe Forschungsgesellschaft mbH, and Exobiosphere have been selected for the European Space Agency Business in Space Growth Network (BSGN) Life Science Industry Accelerator with their joint project 'myrSpaceCardio’, a pioneering initiative to develop next-generation human cardiac tissue models in microgravity. The project addresses a major bottleneck in drug development and cardiac disease research.






